News & Research

  • Mark Davis on immunology research

    Vaccinology has taken great leaps forward in the past decade, largely due to advanced analytical methods as well as a shift in researchers’ focus from rodents to humans.

  • Hints into long COVID

    People with lower levels of an antiviral antibody as well as those with lung disease take longer to clear COVID-19 symptoms, say Stanford Medicine researchers.

  • Keto and Mediterranean good for diabetes

    In a trial of the two low-carb diets, both were similarly effective in controlling blood glucose. Keto’s more severe carb restrictions did not provide additional overall health benefits.

  • ‘Digital human’ helps reduce knee stress

    A computer simulation that relates muscle activation patterns to harmful pressure on the knee helps participants adopt knee-protective strategies as they walk.

  • Pediatric emergency department recognized

    Santa Clara County recognized Stanford’s pediatric emergency department for its ability to handle a broad spectrum of medical emergencies in young patients.

  • Targeting enzyme that fuels cancer cells

    Stanford Medicine researchers have created a molecule that blocks an enzyme thought to be instrumental in causing colon cancer relapse or chemotherapy resistance.

  • Joseph Wu to be AHA president

    Beginning July 2023, Wu will lead the nation’s largest nonprofit organization dedicated to advancing cardiovascular health.

  • Leaders pledge to address climate change

    A roundtable at the White House on reducing the health care industry’s climate-warming emissions includes leaders from Stanford Medicine.

  • Awards for COVID-19 project, media work

    A COVID-19 remembrance project, two videos, an article about bad brain cells and Stanford Medicine magazine have been recognized by the Council for Advancement and Support of Education.

  • Improving clinical trial diversity

    The American Heart Association has provided funding to two Stanford Medicine professors to develop ways to diversify enrollment in heart disease clinical trials.

  • Gummy phlegm and COVID-19

    Levels of a stringy, spongy substance soar in the sputum of COVID-19 patients requiring intubation, accounting for at least some of their breathing trouble. Development of an off-patent drug may prevent it.

  • Stanford Medicine provides monkeypox test

    Stanford Medicine now provides a test for the monkeypox virus. Rapid identification of infected people will help combat the virus’s spread and facilitate patient care.


2022 ISSUE 1

Understanding the world within us

Stanford Medicine's blog about health, medicine, science & innovators


Other Stanford
Medicine News


Featured Topics